Identification marker genetic genomes, methods and kits for identifying or classifying subtypes of breast cancer
A genetic and genomic technology, applied in the direction of biochemical equipment and methods, microbial measurement/inspection, etc., can solve the problems of high malignancy and unreached
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0126] 1. Differential marker genetic genes for identifying or classifying subtypes of breast cancer
[0127] 1-1. Overview
[0128] The first aspect of the present invention is a gene set of differential markers capable of distinguishing subtypes (tissue types) of breast cancer. The differential marker genetic group of the present invention is composed of genes selected from at least 199 genetic gene groups, and can be measured by measuring the occurrence level of a specific gene in the genetic gene group in the test sample. Classify the sample into breast cancer histotype Luminal A, Luminal B (HER2 positive), Luminal B (HER2 negative), HER2 positive, suspected HER2 positive, triple negative, suspected normal, normal, squamous cell carcinoma, phyllodes Any type of tumor cannot be determined.
[0129] 1-2. Definition
[0130] "Breast cancer" generally refers to cancer that develops in the tissues inside the breast, such as the mammary gland and lobules. In addition, breast...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


